Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination

Area of Science:

• Immunology
• Vaccinology
• Infectious Diseases

Background:

• Multisystem inflammatory syndrome (MIS) is a rare, potentially severe condition following infections like COVID-19.
• Reports linking MIS to SARS-CoV-2 vaccination are infrequent.

Observation:

• A 46-year-old male developed MIS-like symptoms 12 days post-Ad26.COV2.S vaccination.
• Symptoms included fever, rash, weakness, pericardial effusion, and elevated inflammatory markers.

Findings:

• The patient's presentation met the diagnostic criteria for MIS.
• Symptoms showed improvement with corticosteroid treatment.

Implications:

• This case suggests a possible association between SARS-CoV-2 vaccination and MIS.
• Further investigation is warranted to understand this potential adverse event.